BCM

Burrage Capital Management Portfolio holdings

AUM $99.7M
This Quarter Return
+15.05%
1 Year Return
+65.92%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$99.7M
AUM Growth
+$99.7M
Cap. Flow
-$25.5M
Cap. Flow %
-25.56%
Top 10 Hldgs %
70.67%
Holding
28
New
3
Increased
3
Reduced
2
Closed
6

Top Buys

1
FOLD icon
Amicus Therapeutics
FOLD
$4.82M
2
VSTM icon
Verastem
VSTM
$2.87M
3
EPZM
Epizyme, Inc
EPZM
$2.26M
4
RVMD icon
Revolution Medicines
RVMD
$1.59M
5
INZY
Inozyme Pharma
INZY
$1.24M

Top Sells

1
PLX icon
Protalix BioTherapeutics
PLX
$9.48M
2
PTCT icon
PTC Therapeutics
PTCT
$7.59M
3
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
$5.47M
4
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
$3.91M
5
FULC icon
Fulcrum Therapeutics
FULC
$3.77M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BCRX icon
1
BioCryst Pharmaceuticals
BCRX
$1.74B
$13.7M 13.71%
864,916
– –
NTLA icon
2
Intellia Therapeutics
NTLA
$1.22B
$10.3M 10.33%
63,634
– –
EPZM
3
DELISTED
Epizyme, Inc
EPZM
$6.95M 6.97%
836,802
+272,247
+48% +$2.26M
EPIX icon
4
ESSA Pharma
EPIX
$11.2M
$6.78M 6.8%
237,442
– –
NEO icon
5
NeoGenomics
NEO
$1.15B
$6.68M 6.7%
147,921
– –
MEIP icon
6
MEI Pharma
MEIP
$160M
$6.64M 6.66%
2,331,313
– –
CRNX icon
7
Crinetics Pharmaceuticals
CRNX
$3.13B
$5.55M 5.57%
294,620
+22,227
+8% +$419K
CYTK icon
8
Cytokinetics
CYTK
$5.96B
$4.84M 4.85%
244,673
– –
FOLD icon
9
Amicus Therapeutics
FOLD
$2.41B
$4.82M 4.83%
+500,000
New +$4.82M
HRMY icon
10
Harmony Biosciences
HRMY
$2.14B
$4.23M 4.25%
150,000
– –
INZY
11
DELISTED
Inozyme Pharma
INZY
$4.13M 4.14%
242,517
+73,044
+43% +$1.24M
YMAB icon
12
Y-mAbs Therapeutics
YMAB
$389M
$3.87M 3.88%
114,454
– –
MIRM icon
13
Mirum Pharmaceuticals
MIRM
$3.75B
$3.56M 3.57%
205,866
– –
ADCT icon
14
ADC Therapeutics
ADCT
$352M
$3.04M 3.05%
124,875
– –
VSTM icon
15
Verastem
VSTM
$570M
$2.87M 2.88%
+705,585
New +$2.87M
MRUS icon
16
Merus
MRUS
$5.05B
$2.75M 2.76%
130,683
– –
GERN icon
17
Geron
GERN
$944M
$2.7M 2.7%
1,912,673
– –
TECX
18
Tectonic Therapeutic, Inc. Common Stock
TECX
$319M
$2.18M 2.18%
244,920
– –
RVMD icon
19
Revolution Medicines
RVMD
$7.35B
$1.59M 1.59%
+50,000
New +$1.59M
BDTX icon
20
Black Diamond Therapeutics
BDTX
$160M
$1.35M 1.35%
110,447
– –
GTHX
21
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1.05M 1.05%
47,708
-70,000
-59% -$1.54M
TPTX
22
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$169K 0.17%
2,164
-70,000
-97% -$5.47M
FULC icon
23
Fulcrum Therapeutics
FULC
$349M
– –
-319,819
Closed -$3.77M
PLX icon
24
Protalix BioTherapeutics
PLX
$131M
– –
-2,125,585
Closed -$9.48M
PTCT icon
25
PTC Therapeutics
PTCT
$4.19B
– –
-160,372
Closed -$7.59M
1
2